Scholar Rock Holding (SRRK) Debt to Equity (2017 - 2026)
Scholar Rock Holding (SRRK) recorded quarterly Debt to Equity of $0.71 in Q1 2026, up 75.38% quarter-over-quarter from $0.41 in Q4 2025, and up 347.29% on a YoY basis from $0.16 in Q1 2025.
Scholar Rock Holding (SRRK) Debt to Equity (2017 - 2026) Analysis & Trends
Scholar Rock Holding's Debt to Equity history runs 10 years deep, the most recent figure standing at $0.71 for Q1 2026.
- In Q1 2026, Debt to Equity rose 347.29% year-over-year to $0.71; the TTM figure through Mar 2026 stood at $0.71 (up 347.29% YoY), while the FY2025 annual figure was $0.41, up 198.58% from the prior year.
- Debt to Equity was $0.71 for Q1 2026 at Scholar Rock Holding, up from $0.41 in the prior quarter.
- In the past five years, Debt to Equity ranged from a high of $0.71 in Q1 2026 to a low of $0.14 in Q4 2024.
- Historically, Debt to Equity has averaged $0.3 across 5 years, with a median of $0.25 in 2023.
- The sharpest annual moves came in 2025 and 2026: Debt to Equity sank 43.09% in 2025, then jumped 347.29% in 2026.
- A 5-year view of Debt to Equity shows it stood at $0.19 in 2022, then gained by 16.18% to $0.22 in 2023, then sank by 38.75% to $0.14 in 2024, then jumped by 198.58% to $0.41 in 2025, then soared by 75.38% to $0.71 in 2026.
- The last three Debt to Equity figures came in at $0.71 (Q1 2026), $0.41 (Q4 2025), and $0.41 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt/Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.32 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Scholar Rock Holding | 6.03 Bn | 5.55 Bn | - | 0.71 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.71 |
| Dec 31, 2025 | 0.41 |
| Sep 30, 2025 | 0.41 |
| Jun 30, 2025 | 0.21 |
| Mar 31, 2025 | 0.16 |
| Dec 31, 2024 | 0.14 |
| Sep 30, 2024 | 0.63 |
| Jun 30, 2024 | 0.37 |
| Mar 31, 2024 | 0.27 |
| Dec 31, 2023 | 0.22 |
| Sep 30, 2023 | 0.30 |
| Jun 30, 2023 | 0.25 |
| Mar 31, 2023 | 0.22 |
| Dec 31, 2022 | 0.19 |
| Sep 30, 2022 | 0.17 |
| Jun 30, 2022 | 0.15 |
| Mar 31, 2022 | 0.29 |
| Dec 31, 2021 | 0.29 |
| Sep 30, 2021 | 0.13 |
| Jun 30, 2021 | 0.11 |